| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA497279
Max Phase: Preclinical
Molecular Formula: C28H39N3O2
Molecular Weight: 449.64
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCCCCCCCCn1nnc3ccccc31)O2
Standard InChI: InChI=1S/C28H39N3O2/c1-20-21(2)27-23(22(3)26(20)32)16-18-28(4,33-27)17-12-8-6-5-7-9-13-19-31-25-15-11-10-14-24(25)29-30-31/h10-11,14-15,32H,5-9,12-13,16-19H2,1-4H3/t28-/m1/s1
Standard InChI Key: VEXAQKBTMMMJFK-MUUNZHRXSA-N
Associated Targets(Human)
Cytochrome P450 4F2 83 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 449.64 | Molecular Weight (Monoisotopic): 449.3042 | AlogP: 6.97 | #Rotatable Bonds: 10 |
| Polar Surface Area: 60.17 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 10.80 | CX Basic pKa: 0.44 | CX LogP: 8.38 | CX LogD: 8.38 |
| Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.34 | Np Likeness Score: 0.18 |
References
| 1. Ohnmacht S, Nava P, West R, Parker R, Atkinson J.. (2008) Inhibition of oxidative metabolism of tocopherols with omega-N-heterocyclic derivatives of vitamin E., 16 (16): [PMID:18656365] [10.1016/j.bmc.2008.07.020] |
Source
Source(1):